Upper Eyelid in Curitiba BR
Surgical rejuvenation of the eyelids or Blepharoplasty is a procedure usually performed on otherwise healthy patients who may have excess skin, muscle, and fat around the eyelids. The operation is done to rejuvenate the eyelids and achieves a more youthful appearance.
Incisions are carefully made along predetermined marks on the skin. These marks are made so the scar will be hidden in natural creases of the skin. Once the incisions are made, the excess skin is removed.
Excess muscle is also carefully removed.
Underneath the muscle, two pockets of fat are exposed. A series of surgical instruments are used to remove the fat.
The incision is closed with small sutures that are usually underneath the skin. The sutures may also be absorbable.
The sutures are usually left in place for three to five days. The patient may have bruising and swelling that will last up to a week or more. Often patients are able to resume fairly normal activities within the first two weeks.
More Curitiba info...
Curitiba Get around
Curitiba has a very simple and practical transportation system. Public transportation consists entirely of buses. There are several different types of bus, each with a different function.
Driving can be difficult for those who are not used to the traffic in Curitiba, specially for first comers. In the central area, there are many one-way streets, parking restrictions as well as pedestrian-only and bus-only streets. Bus lanes are very common in Curitiba, as the city has over 60 km (38 miles) of them. Most avenues are wide and have spacious sidewalks and they are mostly laid out in a grid system in the city center area.
-
Curitiba Understand
Curitiba is the largest city in the prosperous Southern region, and its population is largely descended from German, Ukranian, Russian, Italian and Polish immigrants. The city is known to urban planners worldwide for its innovative public transit system.
There is a great cidade velha (old city) in the center which is restored very well for its 314 years. There is a huge arts and crafts fair every Sunday in the old city that is well worth visiting.
-
Plastic Surgery News...
- A systematic review and meta-analysis published early online in the Lancet Oncology has concluded that patients taking sorafenib have a statistically significant risk of developing hypertension.
Researchers conducted a systematic review and meta-analysis of 9 clinical trials in which a total of 4599 cancer patients (renal cell carcinoma or other solid tumours) had been randomised to receive sorafenib 400mg twice daily, and the incidence of hypertension was reported in the safety data.
The following results were reported:
• Sorafenib was associated with a statistically significantly increased risk of all-grade hypertension in patients with cancer, with a relative risk RR of 6.11 (2.44–15.32], p<0.001) compared with controls.
• For patients assigned sorafenib, the overall incidence of all-grade and high-grade (i.e. grade 3 or 4) hypertension were 23.4% (95% CI 16.0–32.9%) and 5.7% (2.5–12.6%), respectively.
• No significant difference was noted between patients with RCC or a non-RCC malignancy (all grade: RR 1.03 [95% CI 0.73–1.45], p=0.89; high-grade: RR 1.23 [0.76–1.99], p=0.40) who were assigned sorafenib.
The authors also conclude that appropriate monitoring of patients taking sorafenib is strongly recommended to prevent cardiovascular complications.
[Absolute risk figures were not available in the abstract]
- The Mental Health Act Commission report 'Risks, Rights and Recovery' out today (Wednesday 30 January) highlights the shocking level of fear and intimidation that patients experience on mental health wards.